BioVie Inc.
NASDAQ Capital MarketTotal Valuation
BioVie Inc. carries a market capitalization of 12.44M, placing it among publicly traded companies globally. Its enterprise value stands at -3.15M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 12.44M |
| Enterprise Value | -3.15M |
Share Statistics
BioVie Inc. currently has 7.54M shares outstanding.
| Shares Outstanding | 7.54M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | -0.03 |
| P/TBV Ratio | 0.63 |
| P/FCF Ratio | -0.47 |
| P/OCF Ratio | -0.47 |
Financial Position
BioVie Inc. maintains a current ratio of 9.97, meaning it holds 10.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 1.89, indicating elevated leverage, while an interest coverage ratio of -1,076.37 demonstrates limited ability to service its debt obligations.
| Current Ratio | 9.97 |
| Quick Ratio | 9.02 |
| Debt / Equity | 1.89 |
| Debt / EBITDA | -0.01 |
| Interest Coverage | -1,076.37 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -94.45 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
BioVie Inc.'s stock has declined approximately -85.13514% over the past 52 weeks. The 50-day moving average sits at 1.46, while the 200-day moving average is 1.50.
| Beta (5Y) | N/A |
| 52-Week Price Change | -85.13514% |
| 50-Day Moving Average | 1.46 |
| 200-Day Moving Average | 1.50 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -20.37M, while operating income came in at -20.60M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -20.60M |
| Pretax Income | -19.92M |
| Net Income | -19.92M |
| EBITDA | -20.37M |
| EBIT | -20.60M |
| Earnings Per Share (EPS) | -2.89 |
Balance Sheet
BioVie Inc. holds 13.10M in cash and equivalents against 295,717.00 in total debt, resulting in a net debt position of -13.10M. Total book value stands at -368.61M, with working capital of 15.19M providing operational flexibility.
| Cash & Cash Equivalents | 13.10M |
| Total Debt | 295,717.00 |
| Net Debt | -13.10M |
| Equity (Book Value) | -368.61M |
| Book Value Per Share | -53.48 |
| Working Capital | 15.19M |
Cash Flow
BioVie Inc. produced -20.51M in operating cash flow over the past twelve months.
| Operating Cash Flow | -20.51M |
| Capital Expenditures | N/A |
| Free Cash Flow | -20.51M |
| FCF Per Share | -2.98 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -108.37 |
| FCF Yield | -212.54 |
Stock Splits
BioVie Inc.'s most recent stock split took place on July 7, 2025 with a 10:1 split ratio.
| Last Split Date | 7/7/2025 |
| Split Ratio | 10:1 |
Scores
BioVie Inc. posts an Altman Z-Score of -29.93, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -29.93 |